NEW: FDA on Friday cautioned against prescribing hydroxychloroquine to COVID-19 patients outside of hospital settings or clinical trials.
Hydroxychloroquine, and a related compound called chloroquine, is a medication that's been around for decades. It's used to treat malaria, as well as certain autoimmune diseases, including lupus and rheumatoid arthritis.
Enthusiasm for its potential as a treatment for the coronavirus began to build in March, when a Frenchsuggested hydroxychloroquine plus azithromycin might benefit COVID-19 patients. The journal that published the French study, however, later said that the article did not meet its expected standard. A week later, the FDA issued an emergency use authorization for hydroxychloroquine, allowing health care providers to use the medicine for COVID-19 in hospitalized patients with severe disease, even though the drug had not been approved as a specific treatment for the illness, and was known to increase the risk for
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA warns against using hydroxychloroquine for coronavirus outside of hospitalNEW: FDA on Friday cautioned against prescribing hydroxychloroquine to COVID-19 patients outside of hospital settings or clinical trials.
Read more »
There is no evidence suggesting coronavirus can be transmitted by food, FDA commissioner saysThe global coronavirus pandemic has brought countries around the world to a standstill. Here's the latest updates on worldwide Covid-19 cases, deaths, government responses, and more.
Read more »
Coronavirus Outbreak Delays FDA Review of Vaping ProductsThe review is part of a yearslong government effort to regulate the multibillion-dollar vaping industry
Read more »
The FDA just approved Columbia's Covid-19 plasma therapy study, backed by AmazonAmazon backed a study at Columbia University to help determine if it's safe and effective to give plasma collected from those who have recovered from the Covid-19 virus to other severely ill patients.
Read more »
Juul, Rival E-Cigarette Makers Get More Time Before FDA Review Due to CoronavirusJuul Labs and other e-cigarette makers now have until early September to either submit their vaping products for federal review or take them off the U.S. market, after the deadline was extended from May due to the coronavirus pandemic.
Read more »
How to safely sanitize your food and packages according to the FDADo you need to clean your packages before you bring them inside? Via reviewed
Read more »